March 21 Media Roundup
April 29, 2016
Reading Time: 2 minutes
mHealth and Tech
- Can the Apple Watch heart-rate sensor detect atrial fibrillation, a condition that increases likelihood of heart failure or strokes? Developers are on the case to see if it’s possible.
- The just-released “Dementia-Friendly Home” app helps caregivers see and understand the visual and spatial challenges dementia patients may face in their homes.
- SXSW attendees are spotting a shift away from the release of apps at the conference, and towards physical products pushing innovation in their fields. Cognitive enhancing supplements are one of the big hits this year.
- North Carolina researchers have developed a patch alternative to insulin injections. The device “secretes insulin to control blood sugar levels on demand with no risk of inducing hypoglycemia.”
- Smart patches are catching on in healthcare. Lightweight, flexible patches are becoming popular with healthcare providers interested in monitoring patients’ vital signs.
- The federal government is getting serious about using tech to improve health options. The latest efforts include adding mental health providers to a tech-focused pilot program.
- If you didn’t make it to the first week of SXSW, you can still catch President Obama’s chat with the tech community.
- Made by 2Morrow, smoking cessation app SmartQuit is working with GlaxoSmithKlineto help people quit smoking. After completing 2Morrow’s smoking cessation program, smokers are given GSK’s Nicoderm CQ Patch.
- New skincare wearables are getting ready to hit the consumer market. The devices will detect harmful UV exposure and tackle cosmetic skincare problems.
- Dataconomy outlines three ways data will improve the quality of patient care and outcomes, and lead to a more effective health system.
Pharma and Life Sciences
- An experimental vaccine to treat mosquito-borne dengue had a 100% success rate using a new technique for clinical trials. Researchers hope it may lead to additional vaccines for other viruses in the future.
- Scientific American writes about the challenges and drawbacks of precision medicine.
- Industry academics are increasingly joining biotech companies or commercializing their work while holding university positions, allowing them to put their work into action.
- A promising new cancer blood test developed by the Cancer Research UK may become a less invasive way to monitor patients’ tumors and learn more about drug resistance.
- Immunologist researchers are taking a fresh look at gut bacteria in the fight against cancer and medicines that stimulate the body’s natural ability to fight tumors.
- Cambridge Epigenetics was backed with a $21 million round of Series B funding from Google and other investors. A spinoff from the University of Cambridge in England, the company creates epigenetic sequencing technologies.
- Clinical trials are taking a page from the travel industry’s book. A former Kayak executive has launched a website that matches clinical trials with potential patients.